Hims and Hers Health Inc vs Uranium Energy Corp — how do they compare? Hims and Hers Health Inc trades at $32.37 (market cap $7.57B), while Uranium Energy Corp trades at $9.63 (market cap $4.65B). The key difference: Hims and Hers Health Inc is the larger of the two by market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.
| HIMS | UEC | |
|---|---|---|
Market Cap | $7.57B | $4.65B |
Sector | Health | Energy |
52-Week High | $66.18 | $20.14 |
52-Week Low | $14.52 | $8.00 |
Enterprise Value | $7.95B | $4.16B |
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
UEC trades at $9.40, up 1.29% today, but faces bearish technical signals with 18 sell indicators against 2 buys. The company reported a net loss of $87.66 million in 2025 on $66.84 million revenue, with a negative net margin of -513.24% in 2026. Recent news highlights operational challenges, including zero sales in Q3 2026 and wider losses, though strategic assets and $794 million liquidity offer some stability.
Despite analyst consensus favoring buys (87.5%), high execution risks and persistent losses temper near-term optimism. Investment appeal hinges on successful production ramp-up and uranium price recovery, but volatility and cost pressures present significant downside risks for stockholders.
Trailing returns across standard periods
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →